Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer

  • Authors:
    • Hirofumi Shirakawa
    • Toshimitsu Kuronuma
    • Yoshiko Nishimura
    • Takahiro Hasebe
    • Masayuki Nakano
    • Naoto Gotohda
    • Shinichiro Takahashi
    • Toshio Nakagohri
    • Masaru Konishi
    • Nobuaki Kobayashi
    • Taira Kinoshita
    • Tetsuya Nakatsura
  • View Affiliations

  • Published online on: March 1, 2009     https://doi.org/10.3892/ijo_00000190
  • Pages: 649-656
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Primary liver cancers are classified into three types based on their morphology and cytogenetic characteristics hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular and cholangiocarcinoma (CHC). It is often difficult to distinguish these liver tumors. Glypican-3 (GPC3) is serological and histochemical marker of hepatocellular carcinoma. In order to separate these three types of liver cancers, we analyzed the GPC3 expression in 85 liver resection specimens, including 46 HCCs, 28 ICCs and 11 CHCs. GPC3 immunohistochemical staining was used to distinguish HCC from ICC by comparing with the conventional biomarker, α-fetoprotein (AFP). The immunostaining of GPC3 was identified in 78.3% (36/46) of HCCs, 60% (9/15) of well differentiated, 88.9% (16/18) of moderately differentiated and 84.6% (11/13) of poorly differentiated HCCs. It was negative in the ICCs. We confirmed that GPC3 expression is specific to HCC component (8/11, 72.7%) but few samples also showed weakly in ICC component (2/11, 18.2%) of CHC sections among 11 cases compared with HCC biomarkers including AFP and hepatocyto paraffin 1 (HepPar1), and ICC biomarkers cytokeratin (CK) 7 and CK19. Three cases in which the macroscopic features resembled ICC did not express GPC3 even in the pathological HCC component. Most (10/11, 91%) of the pathological cholangiocarcinoma components in CHC showed positive staining for CK7 and CK19. The results of this study suggest that GPC3 is a biomarker that is sensitive and specific to HCC component of CHC, and CK7 and CK19 are markers for pathological cholangiocarcinoma component of CHC.

Related Articles

Journal Cover

March 2009
Volume 34 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kobayashi N, et al: Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol 34: 649-656, 2009.
APA
Shirakawa, H., Kuronuma, T., Nishimura, Y., Hasebe, T., Nakano, M., Gotohda, N. ... Nakatsura, T. (2009). Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. International Journal of Oncology, 34, 649-656. https://doi.org/10.3892/ijo_00000190
MLA
Shirakawa, H., Kuronuma, T., Nishimura, Y., Hasebe, T., Nakano, M., Gotohda, N., Takahashi, S., Nakagohri, T., Konishi, M., Kobayashi, N., Kinoshita, T., Nakatsura, T."Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer". International Journal of Oncology 34.3 (2009): 649-656.
Chicago
Shirakawa, H., Kuronuma, T., Nishimura, Y., Hasebe, T., Nakano, M., Gotohda, N., Takahashi, S., Nakagohri, T., Konishi, M., Kobayashi, N., Kinoshita, T., Nakatsura, T."Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer". International Journal of Oncology 34, no. 3 (2009): 649-656. https://doi.org/10.3892/ijo_00000190